Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Mab™
HUGO-Light™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Peer-Reviewed Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Ostnem1flox/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Ostnem1flox/Cya

Common Name
Ostn-flox
Product ID
S-CKO-08178
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-239790-Ostn-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Ostn-flox Mouse (Catalog S-CKO-08178) were purchased from Cyagen.”
cKO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
cKO Models
Basic Information
Strain Name
Ostn-flox
Strain ID
CKOCMP-239790-Ostn-B6J-VA
Gene Name
Ostn
Product ID
S-CKO-08178
Gene Alias
Ostc
Background
C57BL/6JCya
NCBI ID
239790 (Mouse)
Modification
Conditional knockout
Chromosome
Chr 16 (Mouse)
Phenotype
MGI:2677164
Datasheet
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000066852
NCBI Transcript ID
NM_198112
Target Region
Exon 3
Size of Effective Region
~1.6 kb
Overview of Gene Research
Ostn, also known as Osteocrin, is a gene encoding a secreted myokine. It plays crucial roles in multiple biological processes. It binds to natriuretic peptide receptor 3 (NPR3), inhibits the degradation of natriuretic peptides, and enhances guanylyl cyclase-A (GC-A/NPR1) signaling [3]. It is involved in processes like bone growth, muscle homeostasis, and energy metabolism, and has implications in various diseases [1,2,3,4,5,6]. Genetic models, such as knockout (KO) mouse models, have been valuable in understanding its functions.

In skeletal muscle, RNA sequencing from wasting skeletal muscles of mice with heart failure showed reduced Ostn expression. Generating skeletal muscle-specific Ostn knockout and overexpressing mice demonstrated that reduced skeletal muscle Ostn levels exaggerate, while its overexpression attenuates cardiac dysfunction and myocardial fibrosis during pressure overload [1]. In adriamycin nephropathy, Ostn-transgenic mice and NPR3 knockout mice showed improvement in phenotypes like albuminuria and podocyte injuries, indicating Ostn works through NPR3. Conversely, Ostn KO mice had increased urinary albumin levels [3]. In the context of cardiac hypertrophy, the expression of Ostn was lower in Ang II-treated mouse heart. Overexpression of Ostn attenuated the hypertrophy and fibrosis of the heart in mice induced by Ang II [4]. For diabetic cardiomyopathy, Ostn expression was reduced in diabetic hearts, and its overexpression significantly attenuated cardiac injury and dysfunction in mice with streptozotocin treatment. OSTN silence aggravated cardiomyocyte apoptosis and injury upon hyperglycemic stimulation in vitro [6].

In conclusion, Ostn is essential in maintaining normal physiological functions in muscles, bones, heart, and kidneys. Studies using Ostn KO or overexpressing mouse models have revealed its significance in disease conditions such as heart failure, nephropathy, cardiac hypertrophy, and diabetic cardiomyopathy. These findings provide potential therapeutic targets for these diseases.

References:
1. Szaroszyk, Malgorzata, Kattih, Badder, Martin-Garrido, Abel, Bauersachs, Johann, Heineke, Joerg. 2022. Skeletal muscle derived Musclin protects the heart during pathological overload. In Nature communications, 13, 149. doi:10.1038/s41467-021-27634-5. https://pubmed.ncbi.nlm.nih.gov/35013221/
2. Wang, Dandan, Tan, Lizhi, Zhi, Yihao, Kang, Xiangtao, Liu, Xiaojun. 2024. Genome-wide variation study and inter-tissue communication analysis unveil regulatory mechanisms of egg-laying performance in chickens. In Nature communications, 15, 7069. doi:10.1038/s41467-024-50809-9. https://pubmed.ncbi.nlm.nih.gov/39152103/
3. Handa, Takaya, Mori, Keita P, Ishii, Akira, Yanagita, Motoko, Yokoi, Hideki. 2021. Osteocrin ameliorates adriamycin nephropathy via p38 mitogen-activated protein kinase inhibition. In Scientific reports, 11, 21835. doi:10.1038/s41598-021-01095-8. https://pubmed.ncbi.nlm.nih.gov/34750411/
4. Ji, Mingyue, Zuo, Zhi, Zhang, Mengyuan, Xu, Zhen, Hu, Guoxin. 2022. Osteocrin alleviates cardiac hypertrophy via attenuating oxidative stress. In Peptides, 152, 170773. doi:10.1016/j.peptides.2022.170773. https://pubmed.ncbi.nlm.nih.gov/35218795/
5. Watanabe-Takano, Haruko, Ochi, Hiroki, Chiba, Ayano, Yasoda, Akihiro, Mochizuki, Naoki. . Mechanical load regulates bone growth via periosteal Osteocrin. In Cell reports, 36, 109380. doi:10.1016/j.celrep.2021.109380. https://pubmed.ncbi.nlm.nih.gov/34260913/
6. Zhang, Xin, Hu, Can, Yuan, Xiao-Pin, Ma, Zhen-Guo, Tang, Qi-Zhu. 2021. Osteocrin, a novel myokine, prevents diabetic cardiomyopathy via restoring proteasomal activity. In Cell death & disease, 12, 624. doi:10.1038/s41419-021-03922-2. https://pubmed.ncbi.nlm.nih.gov/34135313/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research